[1] [2] Administered as a once-weekly subcutaneous injection, semaglutide works by enhancing glucose-dependent insulin secretion, suppressing glucagon release, and slowing gastric emptying
Recognizing the symptoms of a yeast infectionsuch as itching, discharge, and discomfortis essential for early intervention
GLP-1 receptor agonists for the reduction of atherosclerotic cardiovascular risk in patients with type 2 diabetes
Known Side Effects and Risks to Be Aware Of The most common side effects are gastrointestinal including nausea, vomiting, and diarrhoea with additional class-associated risks including pancreatitis, gallbladder disease, and increased heart rate
Semaglutide mimics the action of the GLP-1 hormone, which helps regulate blood sugar levels by stimulating insulin secretion and reducing glucagon release
It was also shown that the rate of weight loss remained stable during the trial period